Fig. 1
From: Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis

Flowchart of patients included from the analysis
From: Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis
Flowchart of patients included from the analysis